Frontiers in molecular biosciences · 2025
Mitochondrial mass and mitochondrial membrane potential of peripheral lymphocytes: promising biomarkers of systemic lupus erythematosus.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhao Guanfei, Li Haolong, Miao Yutong, Cheng Linlin, Chen Yuying, Huang Yuan, Zhao Hongyun, Liu Yongmei, Jing Yipei, Wang Shasha, Li Yongzhe, Zhang Rui
Аннотация
BACKGROUND: Mitochondrial dysfunction is implicated in the pathogenesis of systemic lupus erythematosus (SLE). Single-cell mitochondrial mass (SCMM), low mitochondrial membrane potential (MMP-Low) in lymphocytes, and circulating mitochondrial DNA (mtDNA) can reflect mitochondrial impairment and may serve as potential novel biomarkers for SLE.
PURPOSE: We investigated the diagnostic utility of MMP-Low and SCMM in lymphocytes, as well as circulating mtDNA levels, in patients with SLE and examined their correlation with disease activity.
METHODS: Flow cytometry was performed to detect MMP-Low and SCMM in peripheral lymphocytes from patients with SLE (n = 52) and healthy controls (HCs, n = 30). The level of circulating mtDNA was quantified using PCR.
RESULTS: Patients with SLE exhibited significantly decreased MMP-Low in some peripheral lymphocyte subsets. Meanwhile, significantly increased SCMM in some lymphocyte subsets and circulating mtDNA were observed in patients with SLE. CD8+ T naïve (Tn) cell MMP-Low, CD8+ T effector memory cell MMP-Low, CD8+ T central memory (Tcm) cell MMP-Low, and SCMM-CD8+ Tn cells demonstrated a moderate diagnostic value for SLE, with an area under the curve (AUC) above 0.8. Both CD4+ Tcm MMP-Low and SCMM-CD3+CD4+ T cells were significantly associated with the SLE Disease Activity Index 2000 (SLEDAI-2K) and circulating mtDNA levels. These markers also showed significant alternations between inactive and active SLE.
CONCLUSION: Our data showed that patients with SLE exhibit mitochondrial dysfunction. Several MMP-Low and SCMM in CD8+T cell subsets could serve as potential biomarkers for diagnosing SLE. Additionally, CD4+ Tcm MMP-Low and SCMM-CD3+CD4+ T cells were associated with SLE disease activity.
PURPOSE: We investigated the diagnostic utility of MMP-Low and SCMM in lymphocytes, as well as circulating mtDNA levels, in patients with SLE and examined their correlation with disease activity.
METHODS: Flow cytometry was performed to detect MMP-Low and SCMM in peripheral lymphocytes from patients with SLE (n = 52) and healthy controls (HCs, n = 30). The level of circulating mtDNA was quantified using PCR.
RESULTS: Patients with SLE exhibited significantly decreased MMP-Low in some peripheral lymphocyte subsets. Meanwhile, significantly increased SCMM in some lymphocyte subsets and circulating mtDNA were observed in patients with SLE. CD8+ T naïve (Tn) cell MMP-Low, CD8+ T effector memory cell MMP-Low, CD8+ T central memory (Tcm) cell MMP-Low, and SCMM-CD8+ Tn cells demonstrated a moderate diagnostic value for SLE, with an area under the curve (AUC) above 0.8. Both CD4+ Tcm MMP-Low and SCMM-CD3+CD4+ T cells were significantly associated with the SLE Disease Activity Index 2000 (SLEDAI-2K) and circulating mtDNA levels. These markers also showed significant alternations between inactive and active SLE.
CONCLUSION: Our data showed that patients with SLE exhibit mitochondrial dysfunction. Several MMP-Low and SCMM in CD8+T cell subsets could serve as potential biomarkers for diagnosing SLE. Additionally, CD4+ Tcm MMP-Low and SCMM-CD3+CD4+ T cells were associated with SLE disease activity.